BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.

BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q34699520
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaL-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells.Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis.
P2860

BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q34699520
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@ast
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@en
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@nl
type
label
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@ast
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@en
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@nl
prefLabel
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@ast
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@en
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
BCL2L12 is a novel biomarker f ...... e in nasopharyngeal carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932